Melqart Asset Management »

Apogee Therapeutics shares owned by Melqart Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Melqart Asset Management from 13F filings

Historical chart of Melqart Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Melqart Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Melqart Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $16M 117k 132.73

More positions owned by Melqart Asset Management

Warner Bros Discovery Com Ser A (WBD)
PNM Resources (TXNM)
Norfolk Southern (NSC)
Electronic Arts (EA)
Cytokinetics Com New (CYTK)
Penumbra (PEN)
Chart Industries (GTLS)
Abivax Sa Sponsored Ads (ABVX)
Global Payments (GPN)
AES Corporation (AES)
Advanced Micro Devices (AMD)
Asml Hldg Nv N Y Registry Shs (ASML)
NVIDIA Corporation (NVDA)
Indivior Pharmaceuticals (INDV)
Revolution Medicines (RVMD)

View all positions for Melqart Asset Management

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
HBK Investments
Vanguard Capital Management
FMR
Henderson Group
Balyasny Asset Management
State Street Corporation
Driehaus Capital Management
Goldman Sachs Group
Glazer Capital
Paradigm Biocapital Advisors
Vanguard Portfolio Management
Millennium Management
Pentwater Capital Management

View all funds holding Apogee Therapeutics